High-dose influenza vaccine use among patients receiving hemodialysis in the United States, 2010-2013.

ABSTRACT:

Background

Standard influenza vaccines may be of limited benefit to patients with end-stage renal disease (ESRD). These patients may benefit from high-dose influenza vaccine, currently indicated for patients aged ≥65 years. Studies in other populations have demonstrated that high-dose vaccine elicits a stronger immunological response. We compared vaccine uptake in the United States and predictors of receipt for high-dose and standard influenza vaccines.

Methods

Using data from the United States Renal Data System (2010-2013), we conducted a cohort study of 421,482 adult patients on hemodialysis. We examined temporal trends in uptake of high-dose or standard trivalent influenza vaccine each influenza season, and used multivariate logistic regression to assess the association b

SUBMITTER: McGrath LJ 

PROVIDER: S-EPMC6176722 | biostudies-literature | 2018 Oct

REPOSITORIES: biostudies-literature